PROX2
gene geneOn this page
Also known as FLJ36749
Summary
PROX2 (prospero homeobox 2, HGNC:26715) is a protein-coding gene on chromosome 14q24.3, encoding Prospero homeobox protein 2 (Q3B8N5). Transcription regulator.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 283571 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 58 total
- GTEx eGene: eQTL in 13 tissues, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.25 (unconstrained)
- MANE Select transcript:
NM_001243007 - Notable: 58 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26715 |
| Approved symbol | PROX2 |
| Name | prospero homeobox 2 |
| Location | 14q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ36749 |
| Ensembl gene | ENSG00000119608 |
| Ensembl biotype | protein_coding |
| OMIM | 615094 |
| Entrez | 283571 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
MANE Select: ENST00000556489
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 4: 1
ENST00000556489, ENST00000619947, ENST00000673765, ENST00001133424
RefSeq mRNA: 3 — MANE Select: NM_001243007
NM_001080408, NM_001243007, NM_001384314
CCDS: CCDS45136, CCDS73663
Canonical transcript exons
ENST00000556489 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000808246 | 74856801 | 74856995 |
| ENSE00002259765 | 74871103 | 74871237 |
| ENSE00002435005 | 74858407 | 74858514 |
| ENSE00002472312 | 74853033 | 74855302 |
| ENSE00002513655 | 74862530 | 74864008 |
| ENSE00003920954 | 74875895 | 74876145 |
Expression profiles
Bgee: expression breadth ubiquitous, 139 present calls, max score 78.67.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0175 / max 8.2010, expressed in 6 samples.
Highest expression (Bgee): male germ line stem cell (sensu Vertebrata) in testis, pancreatic ductal cell, stromal cell of endometrium, granulocyte, bone marrow cell.
Genetic regulation across tissues (GTEx eQTL / sQTL)
PROX2 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 13 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
13 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Adipose Subcutaneous | eqtl | 6.8e-06 | -0.21 | 14:74811508:G:A |
| Thyroid | eqtl | 7.8e-06 | -0.15 | 14:74762673:A:T |
| Nerve Tibial | eqtl | 2.2e-05 | -0.18 | 14:74774527:TC:T |
| Artery Tibial | eqtl | 3.6e-05 | -0.20 | 14:74910989:C:T |
| Skin Sun Exposed Lower leg | eqtl | 7.8e-05 | +0.20 | 14:74697305:T:C |
| Breast Mammary Tissue | eqtl | 7.8e-04 | +0.21 | 14:74865037:T:C |
| Skin Not Sun Exposed Suprapubic | eqtl | 2.4e-03 | +0.16 | 14:74849911:T:C |
| Lung | eqtl | 3.3e-03 | +0.19 | 14:74771558:T:C |
| Ovary | eqtl | 9.7e-03 | +0.25 | 14:74874436:G:A |
| Adipose Visceral Omentum | eqtl | 1.6e-02 | -0.14 | 14:74797072:A:G |
| Esophagus Mucosa | eqtl | 1.8e-02 | -0.15 | 14:74661722:G:A |
| Esophagus Muscularis | eqtl | 2.4e-02 | +0.70 | 14:75192718:C:T |
| Muscle Skeletal | eqtl | 2.8e-02 | -0.64 | 14:74995893:CTG:C |
FANTOM5 promoters
1 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 144087 | 0.0175 | 6 |
Top tissues by expression
showing 100 of 246 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.67 | silver quality |
| pancreatic ductal cell | CL:0002079 | 67.54 | silver quality |
| stromal cell of endometrium | CL:0002255 | 65.03 | gold quality |
| granulocyte | CL:0000094 | 63.36 | gold quality |
| bone marrow cell | CL:0002092 | 57.61 | gold quality |
| ileal mucosa | UBERON:0000331 | 57.27 | silver quality |
| colonic epithelium | UBERON:0000397 | 56.73 | gold quality |
| tibialis anterior | UBERON:0001385 | 55.70 | silver quality |
| right ovary | UBERON:0002118 | 55.63 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 55.56 | gold quality |
| cortical plate | UBERON:0005343 | 55.34 | silver quality |
| left ovary | UBERON:0002119 | 55.04 | gold quality |
| ganglionic eminence | UBERON:0004023 | 55.04 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| endocervix | UBERON:0000458 | 54.20 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| ovary | UBERON:0000992 | 52.51 | gold quality |
| right uterine tube | UBERON:0001302 | 52.33 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 52.11 | gold quality |
| deltoid | UBERON:0001476 | 51.67 | gold quality |
| body of uterus | UBERON:0009853 | 51.26 | gold quality |
| prefrontal cortex | UBERON:0000451 | 51.10 | gold quality |
| uterine cervix | UBERON:0000002 | 51.07 | gold quality |
| right coronary artery | UBERON:0001625 | 50.80 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 50.79 | gold quality |
| lymph node | UBERON:0000029 | 50.70 | gold quality |
| tonsil | UBERON:0002372 | 50.47 | gold quality |
| endometrium | UBERON:0001295 | 50.34 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| uterus | UBERON:0000995 | 50.12 | gold quality |
| thyroid gland | UBERON:0002046 | 50.11 | gold quality |
| apex of heart | UBERON:0002098 | 50.10 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 49.58 | gold quality |
| cerebellar cortex | UBERON:0002129 | 49.41 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 49.25 | silver quality |
| cortex of kidney | UBERON:0001225 | 49.11 | gold quality |
| skin of leg | UBERON:0001511 | 49.05 | gold quality |
| right adrenal gland | UBERON:0001233 | 49.00 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 48.90 | gold quality |
| female reproductive system | UBERON:0000474 | 48.88 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 48.80 | gold quality |
| cerebellum | UBERON:0002037 | 48.76 | silver quality |
| myometrium | UBERON:0001296 | 48.73 | gold quality |
| muscle tissue | UBERON:0002385 | 48.56 | silver quality |
| ectocervix | UBERON:0012249 | 48.55 | gold quality |
| muscle of leg | UBERON:0001383 | 48.52 | silver quality |
| blood | UBERON:0000178 | 48.35 | silver quality |
| vermiform appendix | UBERON:0001154 | 48.26 | gold quality |
| tibial nerve | UBERON:0001323 | 48.26 | gold quality |
| skin of abdomen | UBERON:0001416 | 48.17 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 48.14 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 47.84 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 47.83 | gold quality |
| nucleus accumbens | UBERON:0001882 | 47.80 | gold quality |
| zone of skin | UBERON:0000014 | 47.77 | gold quality |
| frontal cortex | UBERON:0001870 | 47.75 | gold quality |
| gastrocnemius | UBERON:0001388 | 47.71 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 47.60 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 47.54 | silver quality |
| minor salivary gland | UBERON:0001830 | 47.53 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 47.48 | gold quality |
| spleen | UBERON:0002106 | 47.47 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 47.39 | gold quality |
| neocortex | UBERON:0001950 | 47.33 | gold quality |
| quadriceps femoris | UBERON:0001377 | 47.04 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| vagina | UBERON:0000996 | 46.99 | gold quality |
| heart left ventricle | UBERON:0002084 | 46.96 | silver quality |
| spinal cord | UBERON:0002240 | 46.78 | gold quality |
| small intestine | UBERON:0002108 | 46.75 | gold quality |
| cardiac ventricle | UBERON:0002082 | 46.73 | silver quality |
| saliva-secreting gland | UBERON:0001044 | 46.70 | gold quality |
| caudate nucleus | UBERON:0001873 | 46.69 | gold quality |
| pituitary gland | UBERON:0000007 | 46.60 | gold quality |
| mouth mucosa | UBERON:0003729 | 46.55 | gold quality |
| body of pancreas | UBERON:0001150 | 46.49 | silver quality |
| right frontal lobe | UBERON:0002810 | 46.43 | gold quality |
| lower esophagus | UBERON:0013473 | 46.40 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 46.40 | gold quality |
| caecum | UBERON:0001153 | 46.37 | gold quality |
| cardiac atrium | UBERON:0002081 | 46.34 | gold quality |
| urinary bladder | UBERON:0001255 | 46.27 | silver quality |
| primary visual cortex | UBERON:0002436 | 46.27 | gold quality |
| heart | UBERON:0000948 | 46.26 | silver quality |
| prostate gland | UBERON:0002367 | 46.09 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 46.02 | gold quality |
| esophagus | UBERON:0001043 | 45.91 | gold quality |
| right atrium auricular region | UBERON:0006631 | 45.91 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 45.87 | gold quality |
| kidney | UBERON:0002113 | 45.83 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 45.79 | gold quality |
| fundus of stomach | UBERON:0001160 | 45.77 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 45.73 | gold quality |
| anatomical system | UBERON:0000467 | 45.71 | gold quality |
| brain | UBERON:0000955 | 45.71 | gold quality |
| intestine | UBERON:0000160 | 45.68 | silver quality |
| metanephros | UBERON:0000081 | 45.62 | gold quality |
| multicellular organism | UBERON:0000468 | 45.59 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.26 |
HPA expression
RNA tissue specificity: Tissue enhanced
showing 60 of 71 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Choroid plexus | tissue | 10.1 |
| Nucleus accumbens | tissue | 8.5 |
| Hippocampus | tissue | 7.7 |
| Postcentral gyrus | tissue | 6.9 |
| Locus coeruleus | tissue | 6.8 |
| Bone marrow | tissue | 2.3 |
| Retina | tissue | 1.3 |
| Skin 1 | tissue | 1.1 |
| Lymph node | tissue | 1.0 |
| Appendix | tissue | 1.0 |
| Basal ganglia | tissue | 0.9 |
| Spleen | tissue | 0.9 |
| Caudate putamen | tissue | 0.9 |
| Cerebral cortex | tissue | 0.8 |
| Insular cortex | tissue | 0.8 |
| Prefrontal cortex | tissue | 0.7 |
| Amygdala | tissue | 0.7 |
| Hippocampal formation | tissue | 0.7 |
| Entorhinal cortex | tissue | 0.7 |
| Ventral forebrain | tissue | 0.7 |
| Epididymis | tissue | 0.6 |
| Motor cortex | tissue | 0.6 |
| Putamen | tissue | 0.6 |
| Retrosplenial and cingulate cortex | tissue | 0.6 |
| Retrosplenial cortex | tissue | 0.6 |
| Temporal cortex | tissue | 0.6 |
| Frontal cortex | tissue | 0.5 |
| Occipital cortex | tissue | 0.5 |
| Pituitary gland | tissue | 0.4 |
| Breast | tissue | 0.4 |
| Vagina | tissue | 0.4 |
| Septum | tissue | 0.4 |
| Somatosensory cortex | tissue | 0.4 |
| Testis | tissue | 0.3 |
| Seminal vesicle | tissue | 0.3 |
| Hypothalamus | tissue | 0.3 |
| Placenta | tissue | 0.3 |
| Gallbladder | tissue | 0.3 |
| Tonsil | tissue | 0.3 |
| Periaqueductal gray | tissue | 0.3 |
| Cervix | tissue | 0.2 |
| Stomach 1 | tissue | 0.2 |
| Heart muscle | tissue | 0.2 |
| Pons | tissue | 0.2 |
| Adipose tissue | tissue | 0.2 |
| Esophagus | tissue | 0.2 |
| Salivary gland | tissue | 0.2 |
| Rectum | tissue | 0.2 |
| Skeletal muscle | tissue | 0.2 |
| Colon | tissue | 0.2 |
| Endometrium 1 | tissue | 0.2 |
| Midbrain | tissue | 0.2 |
| Medulla oblongata | tissue | 0.2 |
| Thalamus | tissue | 0.2 |
| Substantia nigra | tissue | 0.2 |
| Thyroid gland | tissue | 0.2 |
| Lung | tissue | 0.2 |
| Small intestine | tissue | 0.2 |
| Prostate | tissue | 0.2 |
| Thymus | tissue | 0.2 |
Brain sub-regions (HPA Brain Atlas): detected in 186; highest nTPM — Flocculonodular lobe (12.5), Vermis (11.1), Temporal white matter (11.0), Parieto-temporal junction (white matter) (10.6), Cerebellar cortex (10.3).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting PROX2 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 95 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-3913-5P | 99.78 | 67.26 | 968 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
Functional genomics
gnomAD constraint: pLI 4.19e-15, LOEUF 1.25, missense Z 0.9 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000556489 — one region, missense o/e 0.92.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | prox2 | ENSDARG00000041952 |
| mus_musculus | Prox2 | ENSMUSG00000042320 |
| rattus_norvegicus | Prox2 | ENSRNOG00000005054 |
| drosophila_melanogaster | pros | FBGN0004595 |
| caenorhabditis_elegans | WBGENE00000448 |
Paralogs (1): PROX1 (ENSG00000117707)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1920672) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| enlarged cecum | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Gallus gallus | Q91018 | 90.1% | Diamond |
| Drosophila virilis | Q9U6A1 | 69.2% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| DLST | protein-coding | 1743 |
| RPS6KL1 | protein-coding | 83694 |
| FCF1 | protein-coding | 51077 |
| YLPM1 | protein-coding | 56252 |
| PGF | protein-coding | 5228 |
| EIF2B2 | protein-coding | 8892 |
| AREL1 | protein-coding | 9870 |
Protein
Protein identifiers
Prospero homeobox protein 2 — Q3B8N5 (reviewed: Q3B8N5)
Alternative names: Homeobox prospero-like protein PROX2
All UniProt accessions (3): A0A0G2JMC2, G3V3G0, Q3B8N5
UniProt curated annotations — full annotation on UniProt →
Function. Transcription regulator. Does not seem to be essential for embryonic development and postnatal survival.
Subcellular location. Nucleus.
Domain organisation. The Prospero-type homeodomain and the adjacent Prospero domain act as a single structural unit, the Homeo-Prospero domain.
Similarity. Belongs to the Prospero homeodomain family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q3B8N5-1 | 1 | yes |
| Q3B8N5-2 | 2 |
RefSeq proteins (3): NP_001073877, NP_001229936, NP_001371243 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR023082 | Homeo_prospero_dom | Domain |
| IPR037131 | Homeo_prospero_dom_sf | Homologous_superfamily |
| IPR039350 | Prospero_homeodomain | Family |
Pfam: PF05044
UniProt features (18 total): region of interest 6, compositionally biased region 4, sequence conflict 3, domain 2, chain 1, splice variant 1, sequence variant 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3B8N5-F1 | 60.97 | 0.32 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Transcription factors, Helix-turn-helix domains, UniProt - Evidence at transcript level
Protein evidence: Evidence at transcript level
Antibody reliability (HPA): IH uncertain
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 85 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_LENS_FIBER_CELL_DIFFERENTIATION, GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_EPITHELIAL_CELL_DEVELOPMENT, GOBP_PANCREAS_DEVELOPMENT, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, chr14q24, GOBP_ENDOTHELIUM_DEVELOPMENT, GOBP_EMBRYO_DEVELOPMENT, GOBP_SENSORY_ORGAN_DEVELOPMENT, GOBP_SENSORY_ORGAN_MORPHOGENESIS, GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE, GOBP_LYMPH_VESSEL_DEVELOPMENT, GOBP_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE
GO Biological Process (12): DNA-templated transcription (GO:0006351), regulation of transcription by RNA polymerase II (GO:0006357), central nervous system development (GO:0007417), pancreas development (GO:0031016), tube development (GO:0035295), cell fate commitment (GO:0045165), anatomical structure formation involved in morphogenesis (GO:0048646), embryonic retina morphogenesis in camera-type eye (GO:0060059), lymphatic endothelial cell differentiation (GO:0060836), lens fiber cell morphogenesis (GO:0070309), hepatocyte differentiation (GO:0070365), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677)
GO Cellular Component (3): chromatin (GO:0000785), nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
36 GO namespaces:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| cellular anatomical structure | 2 |
| gene expression | 1 |
| RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| nervous system development | 1 |
| system development | 1 |
| animal gross anatomical part developmental process | 1 |
| animal organ development | 1 |
| multicellular organism development | 1 |
| anatomical structure development | 1 |
| cell differentiation | 1 |
| cellular developmental process | 1 |
| anatomical structure morphogenesis | 1 |
| developmental process | 1 |
| embryonic morphogenesis | 1 |
| retina morphogenesis in camera-type eye | 1 |
| lymph vessel development | 1 |
| endothelial cell differentiation | 1 |
| cell morphogenesis | 1 |
| lens morphogenesis in camera-type eye | 1 |
| lens fiber cell development | 1 |
| liver development | 1 |
| epithelial cell differentiation | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
showing 15 of 512 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PROX2 | VRTN | Q9H8Y1 | 716 |
| PROX2 | ANKRD61 | A6NGH8 | 576 |
| PROX2 | AREL1 | O15033 | 553 |
| PROX2 | FAM110D | Q8TAY7 | 539 |
| PROX2 | SYNDIG1L | A6NDD5 | 535 |
| PROX2 | YLPM1 | P49750 | 519 |
| PROX2 | CTXN1 | P60606 | 499 |
| PROX2 | HEATR4 | Q86WZ0 | 481 |
| PROX2 | MANSC4 | A6NHS7 | 474 |
| PROX2 | FCF1 | Q9Y324 | 444 |
| PROX2 | SWI5 | Q1ZZU3 | 439 |
| PROX2 | TMEM235 | A6NFC5 | 425 |
| PROX2 | PGPEP1L | A6NFU8 | 422 |
| PROX2 | RPS6KL1 | Q9Y6S9 | 421 |
| PROX2 | RNF215 | Q9Y6U7 | 409 |
Disease & clinical
Genetic variants
Variant evidence for PROX2: 58 ClinVar records (0 pathogenic / likely pathogenic); 8 GWAS associations.
ClinVar
58 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 50 |
| Likely benign | 2 |
| Benign | 3 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 24 predictions of 411):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 14:74855322 | acceptor_gain | 0.9900 | |
| 14:74875893–74875894 | donor_loss | 0.9900 | 5 |
| 14:74856799–74856800 | donor_loss | 0.9800 | 5 |
| 14:74856799 | donor_loss | 0.9700 | |
| 14:74856996–74856998 | acceptor_loss | 0.9500 | 7 |
| 14:74857006 | acceptor_loss | 0.9500 | |
| 14:74863408 | donor_gain | 0.9400 | |
| 14:74856814 | donor_gain | 0.9100 | |
| 14:74857002 | acceptor_loss | 0.8800 | |
| 14:74855313 | acceptor_gain | 0.8700 |
AlphaMissense
566 missense substitutions predicted likely pathogenic (of 3,870 scored), across 139 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| F487 | 8 | 0.959 | 0.993 |
| F484 | 8 | 0.956 | 0.996 |
| F467 | 8 | 0.944 | 0.988 |
| S485 | 8 | 0.939 | 0.997 |
| F452 | 8 | 0.938 | 0.995 |
| N486 | 8 | 0.924 | 0.992 |
| H528 | 8 | 0.895 | 0.989 |
| D561 | 8 | 0.889 | 0.952 |
| D578 | 8 | 0.889 | 0.952 |
| F541 | 8 | 0.884 | 0.971 |
| F472 | 8 | 0.883 | 0.977 |
| H444 | 8 | 0.788 | 0.938 |
| W566 | 7 | 0.986 | 0.997 |
| E489 | 7 | 0.980 | 0.992 |
| W483 | 7 | 0.977 | 0.997 |
| F490 | 7 | 0.968 | 0.997 |
| F552 | 7 | 0.966 | 0.995 |
| K567 | 7 | 0.934 | 0.997 |
| K482 | 7 | 0.931 | 0.995 |
| K568 | 7 | 0.927 | 0.981 |
HPA cancer prognostics
RNA cancer specificity: Not detected
Disease associations
OMIM: gene MIM:615094 | disease phenotypes:
GWAS associations
8 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST90002393_41 | Monocyte count | 8e-17 |
| GCST90000514_10 | Gastroesophageal reflux disease | 2e-9 |
| GCST005238_3 | Mood instability | 3e-9 |
| GCST005839_15 | Depression | 4e-9 |
| GCST006697_28 | Parental longevity (combined parental attained age, Martingale residuals) | 2e-8 |
| GCST009145_7 | Total cholesterol levels | 1e-7 |
| GCST006701_9 | Parental longevity (father’s attained age) | 2e-7 |
| GCST005237_3 | Mood instability | 1e-6 |
EFO canonical traits (from GWAS)
4 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0008475 | mood instability measurement |
| EFO:0007796 | parental longevity |
| EFO:0004574 | total cholesterol measurement |
| EFO:0005091 | monocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Malathion | decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cyclosporine | increases methylation | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): gastroesophageal reflux disease